CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 49 filers reported holding CYTOSORBENTS CORP in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $393,000 | +67.9% | 30,500 | +48.8% | 0.00% | – |
| Q2 2018 | $234,000 | +70.8% | 20,500 | +5.1% | 0.00% | – |
| Q1 2018 | $137,000 | +39.8% | 19,500 | +30.0% | 0.00% | – |
| Q4 2017 | $98,000 | -21.0% | 15,000 | -25.0% | 0.00% | – |
| Q3 2017 | $124,000 | -23.9% | 20,000 | -47.4% | 0.00% | – |
| Q2 2017 | $163,000 | +132.9% | 38,000 | +145.2% | 0.00% | – |
| Q1 2017 | $70,000 | +27.3% | 15,500 | +55.0% | 0.00% | – |
| Q4 2016 | $55,000 | -14.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $64,000 | +39.1% | 10,000 | -2.0% | 0.00% | – |
| Q2 2016 | $46,000 | +53.3% | 10,200 | +32.5% | 0.00% | – |
| Q1 2016 | $30,000 | +15.4% | 7,700 | +63.8% | 0.00% | – |
| Q4 2015 | $26,000 | +2500.0% | 4,700 | +2250.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | +200.0% | 200 | +100.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |